Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function

Brain, Behavior, and Immunity

Volumn 43, Issue , 2015, Pages 76-85

  Norden, Diana M ^a   Bicer, Sabahattin ^a   Clark, Yvonne ^a   Jing, Runfeng ^a   Henry, Christopher J ^a   Wold, Loren E ^a   Reiser, Peter J ^a   Godbout, Jonathan P ^a   McCarthy, Donna O ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer; Cytokines; Depression; Fatigue; Minocycline; Neuroinflammation

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MINOCYCLINE; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN;

ADULT; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BICEPS BRACHII MUSCLE; CANCER FATIGUE; CANCER PATIENT; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIM TEST; GASTROCNEMIUS MUSCLE; GRIP STRENGTH; HIPPOCAMPUS; LOCOMOTION; MOOD CHANGE; MOUSE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; SOLEUS MUSCLE; SUCROSE PREFERENCE TEST; TUMOR CELL INOCULATION; TUMOR GROWTH; TUMOR VOLUME; ADENOCARCINOMA; ANIMAL; ANIMAL BEHAVIOR; CANCER TRANSPLANTATION; COLON TUMOR; COMPLICATION; DISEASE COURSE; DISEASE MODEL; FATIGUE; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; SKELETAL MUSCLE;

ADENOCARCINOMA; ANIMALS; BEHAVIOR, ANIMAL; COLONIC NEOPLASMS; DEPRESSION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATIGUE; FEMALE; MICE; MOTOR ACTIVITY; MUSCLE, SKELETAL; NEOPLASM TRANSPLANTATION; QUALITY OF LIFE;

EID: 84919456349     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.07.013     Document Type: Article

References (52)

1. Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., Guttridge D.C. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 2004, 114:370-378.
2. Baracos V.E., Reiman T., Mourtzakis M., Gioulbasanis I., Antoun S. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am. J. Clin. Nutr. 2010, 91:1133S-1137S.
3. Berger A.M., Gerber L.H., Mayer D.K. Cancer-related fatigue: implications for breast cancer survivors. Cancer 2012, 118:2261-2269.
4. Bicer S., Reiser P.J., Ching S., Quan N. Induction of muscle weakness by local inflammation: an experimental animal model. Inflamm. Res. 2009, 58:175-183.
5. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun. 2007, 21:863-871.
6. Bower J.E., Lamkin D.M. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav. Immun. 2013, 30(Suppl.):S48-57.
7. Bower J.E., Ganz P.A., Irwin M.R., Kwan L., Breen E.C., Cole S.W. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?. J. Clin. Oncol. 2011, 29:3517-3522.
8. Braun T.P., Zhu X., Szumowski M., Scott G.D., Grossberg A.J., Levasseur P.R., Graham K., Khan S., Damaraju S., Colmers W.F., et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J. Exp. Med. 2011, 208:2449-2463.
9. Cao D.X., Wu G.H., Zhang B., Quan Y.J., Wei J., Jin H., Jiang Y., Yang Z.A. Resting energy expenditure and body composition in patients with newly detected cancer. Clin. Nutr. 2010, 29:72-77.
10. Carmichael M.D., Davis J.M., Murphy E.A., Brown A.S., Carson J.A., Mayer E.P., Ghaffar A. Role of brain IL-1beta on fatigue after exercise-induced muscle damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1344-1348.
11. Cosper P.F., Leinwand L.A. Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res. 2011, 71:1710-1720.
12. Diffee G.M., Kalfas K., Al-Majid S., McCarthy D.O. Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am. J. Physiol. Cell Physiol. 2002, 283:C1376-1382.
13. Donnelly D.J., Gensel J.C., Ankeny D.P., van Rooijen N., Popovich P.G. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J. Neurosci. Methods 2009, 181:36-44.
14. Fearon K.C., Glass D.J., Guttridge D.C. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012, 16:153-166.
15. Gielissen M.F., Verhagen S., Witjes F., Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J. Clin. Oncol. 2006, 24:4882-4887.
16. Godbout J.P., Moreau M., Lestage J., Chen J., Sparkman N.L., Connor O., Castanon N., Kelley K.W., Dantzer R., Johnson R.W. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008, 33:2341-2351.
17. Graves E., Ramsay E., McCarthy D.O. Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma. Res. Nurs. Health 2006, 29:87-97.
18. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
19. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflamm. 2008, 5:15.
20. Hofman M., Ryan J.L., Figueroa-Moseley C.D., Jean-Pierre P., Morrow G.R. Cancer-related fatigue: the scale of the problem. Oncologist 2007, 12(Suppl. 1):4-10.
21. Hopwood N., Maswanganyi T., Harden L.M. Comparison of anorexia, lethargy, and fever induced by bacterial and viral mimetics in rats. Can. J. Physiol. Pharmacol. 2009, 87:211-220.
22. Husson O., Nieuwlaat W.A., Oranje W.A., Haak H.R., van de Poll-Franse L.V., Mols F. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid 2013, 23:1247-1255.
23. Johns N., Hatakeyama S., Stephens N.A., Degen M., Degen S., Frieauff W., Lambert C., Ross J.A., Roubenoff R., Glass D.J., et al. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLoS ONE 2014, 9:e83618.
24. Kim H.J., Barsevick A.M., Fang C.Y., Miaskowski C. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients. Cancer Nurs. 2012, 35:E1-E20.
25. Kirkova J., Aktas A., Walsh D., Davis M.P. Cancer symptom clusters: clinical and research methodology. J. Palliat. Med. 2011, 14:1149-1166.
26. Lamkin D.M., Lutgendorf S.K., Lubaroff D., Sood A.K., Beltz T.G., Johnson A.K. Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing. Brain Behav. Immun. 2011, 25:555-564.
27. Minton O., Alexander S., Stone P.C. Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment. Breast Cancer Res. Treat. 2012, 136:513-520.
28. Mols F., Husson O., Roukema J.A., van de Poll-Franse L.V. Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3080 cancer survivors from the PROFILES registry. J. Cancer Surviv. 2013, 7:484-492.
29. Murphy K.T., Chee A., Trieu J., Naim T., Lynch G.S. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis. Model. Mech. 2012, 5:533-545.
30. Murphy K.T., Chee A., Trieu J., Naim T., Lynch G.S. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia. Int. J. Cancer 2013, 133:1234-1246.
31. Nikodemova M., Duncan I.D., Watters J.J. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J. Neurochem. 2006, 96:314-323.
32. Novak C.M., Burghardt P.R., Levine J.A. The use of a running wheel to measure activity in rodents: relationship to energy balance, general activity, and reward. Neurosci. Biobehav. Rev. 2012, 36:1001-1014.
33. Okayama T., Kokura S., Ishikawa T., Adachi S., Hattori T., Takagi T., Handa O., Naito Y., Yoshikawa T. Antitumor effect of pretreatment for colon cancer cells with hyperthermia plus geranylgeranylacetone in experimental metastasis models and a subcutaneous tumor model of colon cancer in mice. Int. J. Hyperthermia 2009, 25:141-149.
34. Pertl M.M., Hevey D., Boyle N.T., Hughes M.M., Collier S., O'Dwyer A.M., Harkin A., Kennedy M.J., Connor T.J. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy. Brain Behav. Immun. 2013, 34:108-119.
35. Phillips S.M., McAuley E. Physical activity and fatigue in breast cancer survivors: a panel model examining the role of self-efficacy and depression. Cancer Epidemiol. Biomarkers Prev. 2013, 22:773-781.
36. Pyter L.M., Pineros V., Galang J.A., McClintock M.K., Prendergast B.J. Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9069-9074.
37. Roberts B.M., Frye G.S., Ahn B., Ferreira L.F., Judge A.R. Cancer cachexia decreases specific force and accelerates fatigue in limb muscle. Biochem. Biophys. Res. Commun. 2013, 435:488-492.
38. Saligan L.N., Kim H.S. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav. Immun. 2012, 26:830-848.
39. Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int. J. Biochem. Cell Biol. 2013, 45:2121-2129.
40. Schmitt T.L., Martignoni M.E., Bachmann J., Fechtner K., Friess H., Kinscherf R., Hildebrandt W. Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia. J. Mol. Med. (Berl.) 2007, 85:647-654.
41. Taskin S., Stumpf V.I., Bachmann J., Weber C., Martignoni M.E., Friedrich O. Motor protein function in skeletal abdominal muscle of cachectic cancer patients. J. Cell Mol. Med. 2014, 18:69-79.
42. Toledo M., Busquets S., Sirisi S., Serpe R., Orpi M., Coutinho J., Martinez R., Lopez-Soriano F.J., Argiles J.M. Cancer cachexia: physical activity and muscle force in tumour-bearing rats. Oncol. Rep. 2011, 25:189-193.
43. Toth M.J., Miller M.S., Callahan D.M., Sweeny A.P., Nunez I., Grunberg S.M., Der-Torossian H., Couch M.E., Dittus K. Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics. J. Appl. Physiol. 1985, 114:858-868.
44. Vissers P.A., Thong M.S., Pouwer F., Zanders M.M., Coebergh J.W., van de Poll-Franse L.V. The impact of comorbidity on health-related quality of life among cancer survivors: analyses of data from the PROFILES registry. J. Cancer Surviv. 2013, 7:602-613.
45. Wang X.S., Williams L.A., Krishnan S., Liao Z., Liu P., Mao L., Shi Q., Mobley G.M., Woodruff J.F., Cleeland C.S. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav. Immun. 2012, 26:699-705.
46. Weber M.A., Krakowski-Roosen H., Schroder L., Kinscherf R., Krix M., Kopp-Schneider A., Essig M., Bachert P., Kauczor H.U., Hildebrandt W. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol. 2009, 48:116-124.
47. Wohleb E.S., Hanke M.L., Corona A.W., Powell N.D., Stiner L.M., Bailey M.T., Nelson R.J., Godbout J.P., Sheridan J.F. Beta-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 2011, 31:6277-6288.
48. Wood L.J., Weymann K. Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster. Curr. Opin. Support. Palliat. Care 2013, 7:54-59.
49. Wood L.J., Nail L.M., Gilster A., Winters K.A., Elsea C.R. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol. Nurs. Forum 2006, 33:535-542.
50. Xu H., Crawford D., Hutchinson K.R., Youtz D.J., Lucchesi P.A., Velten M., McCarthy D.O., Wold L.E. Myocardial dysfunction in an animal model of cancer cachexia. Life Sci. 2011, 88:406-410.
51. Yang M., Kim J., Kim J.-S., Kim S.-H., Kim J.-C., Kang M.-J., Jung U., Shin T., Wang H., Moon C. Hippocampal dysfunctions in tumor-bearing mice. Brain Behav. Immun. 2014, 36:147-155.
52. Zombeck J.A., Fey E.G., Lyng G.D., Sonis S.T. A clinically translatable mouse model for chemotherapy-related fatigue. Comp. Med. 2013, 63:491-497.